Works matching AU MAHAFFEY, KENNETH W.

Results: 193

Retention and characteristics associated with remote questionnaire completion in a general population cohort study: the project baseline health study.

Published in:

Frontiers in Digital Health, 2025, p. 1, doi. 10.3389/fdgth.2025.1520132

By:

Carroll, Megan K.;
Faheem, Safa;
Bouteiller, Jean;
Hernandez, Adrian;
Mahaffey, Kenneth W.;
Mega, Jessica L.;
Pagidipati, Neha;
Schaack, Terry;
Shah, Svati H.;
Shashidhar, Sumana;
Swope, Susan;
Williams, Donna;
Plowman, R. Scooter;
Simard, Edgar P.;
Short, Sarah A.;
Sullivan, Shannon S.

Publication type:

Article

The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials.

Published in:

Journal of the American Geriatrics Society, 2025, v. 73, n. 6, p. 1787, doi. 10.1111/jgs.19444

By:

Nguyen, Tu N.;
Yu, Jie;
Perkovic, Vlado;
Jardine, Meg;
Mahaffey, Kenneth W.;
Chow, Clara K.;
Arnott, Clare;
Lindley, Richard I.

Publication type:

Article

Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.

Published in:

JAMA Network Open, 2021, v. 4, n. 7, p. e2117963, doi. 10.1001/jamanetworkopen.2021.17963

By:

Goyal, Akash;
Schibler, Tony;
Alhanti, Brooke;
Hannan, Karen L.;
Granger, Christopher B.;
Blazing, Michael A.;
Lopes, Renato D.;
Alexander, John H.;
Peterson, Eric D.;
Rao, Sunil V.;
Green, Jennifer B.;
Roe, Matthew T.;
Rorick, Tyrus;
Berdan, Lisa G.;
Reist, Craig;
Mahaffey, Kenneth W.;
Harrington, Robert A.;
Califf, Robert M.;
Patel, Manesh R.;
Hernandez, Adrian F.

Publication type:

Article

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685

By:

Cardoza, Kathryn;
Kang, Amy;
Smyth, Brendan;
Yi, Tae Won;
Pollock, Carol;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Wheeler, David C.;
Zhang, Hong;
Cannon, Christopher P.;
Perkovic, Vlado;
Arnott, Clare;
Levin, Adeera;
Mahaffey, Kenneth W.

Publication type:

Article

Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678

By:

Tangri, Navdeep;
Ferguson, Thomas W.;
Bamforth, Ryan J.;
Leon, Silvia J.;
Arnott, Clare;
Mahaffey, Kenneth W.;
Kotwal, Sradha;
Heerspink, Hiddo J. L.;
Perkovic, Vlado;
Fletcher, Robert A.;
Neuen, Brendon L.

Publication type:

Article

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340

By:

Sharma, Abhinav;
Marques, Pedro;
Neuen, Brendon L.;
Fletcher, Robert A.;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Arnott, Clare;
Levin, Adeera;
Verma, Subodh;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091

By:

Kang, Amy;
Smyth, Brendan;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Di Tanna, Gian Luca;
Zhang, Hong;
Arnott, Clare;
Hockham, Carinna;
Agarwal, Rajiv;
Bakris, George;
Charytan, David M.;
de Zeeuw, Dick;
Greene, Tom;
Levin, Adeera;
Pollock, Carol;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Jardine, Meg J.

Publication type:

Article

Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065

By:

Yi, Tae Won;
Wong, Michelle M.Y.;
Neuen, Brendon L.;
Arnott, Clare;
Poirier, Paul;
Seufert, Jochen;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Wheeler, David C.;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Levin, Adeera

Publication type:

Article

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2038, doi. 10.1111/dom.15057

By:

Tsoukas, Michael A.;
Woo, Vincent;
Tobe, Sheldon W.;
Slee, April;
Rapattoni, Wally;
Ang, Fernando G.;
Seufert, Jochen;
Neuen, Brendon L.;
Arnott, Clare;
Mahaffey, Kenneth W.;
Wheeler, David C.

Publication type:

Article

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978

By:

Koshino, Akihiko;
Oshima, Megumi;
Arnott, Clare;
Fletcher, Robert A.;
Bakris, George L.;
Jardine, Meg;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Pollock, Carol;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.

Publication type:

Article

Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832

By:

Nunes, Julio C.;
Yu, Jie;
Arnott, Clare;
Jardine, Meg J.;
Perkovic, Vlado;
Mahaffey, Kenneth W.

Publication type:

Article

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772

By:

Li, Chao;
Yu, Jie;
Hockham, Carinna;
Perkovic, Vlado;
Neuen, Brendon L.;
Badve, Sunil V.;
Houston, Lauren;
Lee, Vivian Y. J.;
Barraclough, Jennifer Y.;
Fletcher, Robert A.;
Mahaffey, Kenneth W.;
Heerspink, Hiddo J. L.;
Cannon, Christopher P.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671

By:

Barraclough, Jennifer Y.;
Yu, Jie;
Figtree, Gemma A.;
Perkovic, Vlado;
Heerspink, Hiddo J. L.;
Neuen, Brendon L.;
Cannon, Christopher P.;
Mahaffey, Kenneth W.;
Schutte, Aletta E.;
Neal, Bruce;
Arnott, Clare

Publication type:

Article

Effects of canagliflozin on major adverse cardiovascular events by baseline estimated glomerular filtration rate: Pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 12, doi. 10.1111/dom.14539

By:

Weir, Matthew R.;
Gogate, Jagadish;
Damaraju, C.V.;
Correa‐Rotter, Ricardo;
Mahaffey, Kenneth W.

Publication type:

Article

Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525

By:

Feng, Kent Y.;
Li, JingWei;
Ianus, Juliana;
de Zeeuw, Dick;
Fulcher, Greg R.;
Pfeifer, Michael;
Matthews, David R.;
Jardine, Meg J.;
Perkovic, Vlado;
Neal, Bruce;
Mahaffey, Kenneth W.

Publication type:

Article

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386

By:

Arnott, Clare;
Li, Jing‐Wei;
Cannon, Christopher P.;
Zeeuw, Dick;
Neuen, Brendon L.;
Heerspink, Hiddo J. L.;
Charytan, David M.;
Agarwal, Anubha;
Huffman, Mark D.;
Figtree, Gemma A.;
Bakris, George;
Chang, Tara I‐Hsin;
Feng, Kent;
Rosenthal, Norman;
Zinman, Bernard;
Jardine, Meg J.;
Perkovic, Vlado;
Neal, Bruce;
Mahaffey, Kenneth W.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226

By:

Neuen, Brendon L.;
Arnott, Clare;
Perkovic, Vlado;
Figtree, Gemma;
Zeeuw, Dick;
Fulcher, Greg;
Jun, Min;
Jardine, Meg J.;
Zoungas, Sophia;
Pollock, Carol;
Mahaffey, Kenneth W.;
Neal, Bruce;
Heerspink, Hiddo J. L.

Publication type:

Article

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143

By:

Matthews, David R.;
Wysham, Carol;
Davies, Melanie;
Slee, April;
Alba, Maria;
Lee, Mary;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Neal, Bruce

Publication type:

Article

Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, p. 46, doi. 10.1111/dom.13987

By:

Rhee, Jinnie J.;
Jardine, Meg J.;
Chertow, Glenn M.;
Mahaffey, Kenneth W.

Publication type:

Article

Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 530, doi. 10.1111/dom.13920

By:

Ohkuma, Toshiaki;
Van Gaal, Luc;
Shaw, Wayne;
Mahaffey, Kenneth W.;
Zeeuw, Dick;
Matthews, David R.;
Perkovic, Vlado;
Neal, Bruce

Publication type:

Article

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924

By:

Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Fulcher, Greg;
Erondu, Ngozi;
Desai, Mehul;
Shaw, Wayne;
Law, Gordon;
Walton, Marc K.;
Rosenthal, Norm;
de Zeeuw, Dick;
Matthews, David R.

Publication type:

Article

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829

By:

Neal, Bruce;
Perkovic, Vlado;
Matthews, David R.;
Mahaffey, Kenneth W.;
Fulcher, Greg;
Meininger, Gary;
Erondu, Ngozi;
Desai, Mehul;
Shaw, Wayne;
Vercruysse, Frank;
Yee, Jacqueline;
Deng, Hsiaowei;
de Zeeuw, Dick

Publication type:

Article

Diabetes and heart failure post-acute myocardial infarction: Important associations and need for evidence-based interventions.

Published in:

2020

By:

Parizo, Justin;
Mahaffey, Kenneth W

Publication type:

Editorial

Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

Published in:

2000

By:

Alexander, John H.;
Sparapani, Rodney A.;
Mahaffey, Kenneth W.;
Deckers, Jaap W.;
Newby, L. Kristin;
Ohman, E. Magnus;
Corbalan, Ramon;
Chierchia, Sergio L.;
Boland, Jean B.;
Simoons, Maarten L.;
Califf, Robert M.;
Topol, Eric J.;
Harrington, Robert A.;
Alexander, J H;
Sparapani, R A;
Mahaffey, K W;
Deckers, J W;
Newby, L K;
Ohman, E M;
Corbalán, R

Publication type:

journal article

ST-segment Yükselmeli Akut Miyokart Enfarktüsü ile Başvuran Hastaların Tedavisine İlişkin ESC Kılavuzu.

Published in:

Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2013, v. 41, p. 1

By:

Steg, Gabriel;
James, Stefan K.;
Atar, Dan;
Badano, Luigi P.;
Blömstrom-Lundqvist, Carina;
Borger, Michael A.;
Di Mario, Carl;
Dickstein, Kenneth;
Ducroc, Gregory;
Fernandez-Aviles, Francisco;
Gershlic, Anthony H.;
Giannuzzi, Pantaleo;
Halvorse, Sigrun;
Huber, Kurt;
Juni, Peter;
Kastrati, Adnan;
Knuuti, Juhani;
Lenzen, Mattie J.;
Mahaffey, Kenneth W.;
Valgimigli, Marco

Publication type:

Article

Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial.

Published in:

JGIM: Journal of General Internal Medicine, 2008, v. 23, n. 3, p. 310, doi. 10.1007/s11606-007-0498-4

By:

Mahaffey, Kenneth W.;
Yang, Qinghong;
Pieper, Karen S.;
Antman, Elliott M.;
White, Harvey D.;
Goodman, Shaun G.;
Cohen, Marc;
Kleiman, Neal S.;
Langer, Anatoly;
Aylward, Philip E.;
Col, Jacques J.;
Reist, Craig;
Ferguson, James J.;
Califf, Robert M.

Publication type:

Article

Trade-off ofmyocardial infarction vs. bleeding types onmortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.

Published in:

European Heart Journal, 2017, v. 38, n. 11, p. 804, doi. 10.1093/eurheartj/ehw525

By:

Valgimigli, Marco;
Costa, Francesco;
Lokhnygina, Yuliya;
Clare, Robert M.;
Wallentin, Lars;
Moliterno, David J.;
Armstrong, Paul W.;
White, Harvey D.;
Held, Claes;
Aylward, Philip E.;
Van deWerf, Frans;
Harrington, Robert A.;
Mahaffey, Kenneth W.;
Tricoci, Pierluigi

Publication type:

Article

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.

Published in:

European Heart Journal, 2016, v. 37, n. 14, p. 1122, doi. 10.1093/eurheartj/ehv498

By:

Gutierrez, J. Antonio;
Harrington, Robert A.;
Blankenship, James C.;
Stone, Gregg W.;
Steg, Ph. Gabriel;
Gibson, C. Michael;
Hamm, Christian W.;
Price, Matthew J.;
Généreux, Philippe;
Prats, Jayne;
Deliargyris, Efthymios N.;
Mahaffey, Kenneth W.;
White, Harvey D.;
Bhatt, Deepak L.

Publication type:

Article

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.

Published in:

European Heart Journal, 2015, v. 36, n. 46, p. 3258, doi. 10.1093/eurheartj/ehv476

By:

O'Brien, Emily C.;
Simon, DaJuanicia N.;
Thomas, Laine E.;
Hylek, Elaine M.;
Gersh, Bernard J.;
Ansell, Jack E.;
Kowey, Peter R.;
Mahaffey, Kenneth W.;
Chang, Paul;
Fonarow, Gregg C.;
Pencina, Michael J.;
Piccini, Jonathan P.;
Peterson, Eric D.

Publication type:

Article

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.

Published in:

European Heart Journal, 2015, v. 36, n. 5, p. 288

By:

Steinberg, Benjamin A.;
Hellkamp, Anne S.;
Lokhnygina, Yuliya;
Patel, Manesh R.;
Breithardt, Günter;
Hankey, Graeme J.;
Becker, Richard C.;
Singer, Daniel E.;
Halperin, Jonathan L.;
Hacke, Werner;
Nessel, Christopher C.;
Berkowitz, Scott D.;
Mahaffey, Kenneth W.;
Fox, Keith A.A.;
Califf, Robert M.;
Piccini, Jonathan P.

Publication type:

Article

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.

Published in:

European Heart Journal, 2014, v. 35, n. 47, p. 3377, doi. 10.1093/eurheartj/ehu305

By:

Breithardt, Günter;
Baumgartner, Helmut;
Berkowitz, Scott D.;
Hellkamp, Anne S.;
Piccini, Jonathan P.;
Stevens, Susanna R.;
Lokhnygina, Yuliya;
Patel, Manesh R.;
Halperin, Jonathan L.;
Singer, Daniel E.;
Hankey, Graeme J.;
Hacke, Werner;
Becker, Richard C.;
Nessel, Christopher C.;
Mahaffey, Kenneth W.;
Fox, Keith A. A.;
Califf, Robert M.

Publication type:

Article

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Published in:

European Heart Journal, 2014, v. 35, n. 28, p. 1873

By:

Piccini, Jonathan P.;
Garg, Jyotsna;
Patel, Manesh R.;
Lokhnygina, Yuliya;
Goodman, Shaun G.;
Becker, Richard C.;
Berkowitz, Scott D.;
Breithardt, Günter;
Hacke, Werner;
Halperin, Jonathan L.;
Hankey, Graeme J.;
Nessel, Christopher C.;
Mahaffey, Kenneth W.;
Singer, Daniel E.;
Califf, Robert M.;
Fox, Keith A. A.

Publication type:

Article

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

Published in:

European Heart Journal, 2014, v. 35, n. 4, p. 242, doi. 10.1093/eurheartj/eht492

By:

Jones, William Schuyler;
Hellkamp, Anne S.;
Halperin, Jonathan;
Piccini, Jonathan P.;
Breithardt, Gunter;
Singer, Daniel E.;
Fox, Keith A.A.;
Hankey, Graeme J.;
Mahaffey, Kenneth W.;
Califf, Robert M.;
Patel, Manesh R.

Publication type:

Article

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.

Published in:

European Heart Journal, 2014, v. 35, n. 4, p. 233

By:

Mahaffey, Kenneth W.;
Stevens, Susanna R.;
White, Harvey D.;
Nessel, Christopher C.;
Goodman, Shaun G.;
Piccini, Jonathan P.;
Patel, Manesh R.;
Becker, Richard C.;
Halperin, Jonathan L.;
Hacke, Werner;
Singer, Daniel E.;
Hankey, Graeme J.;
Califf, Robert M.;
Fox, Keith A.A.;
Breithardt, Günter

Publication type:

Article

Atrial fibrillation: a spectrum of risk with a uniform treatment effect of novel anticoagulants?

Published in:

European Heart Journal, 2013, v. 34, n. 31, p. 2429, doi. 10.1093/eurheartj/eht205

By:

Mahaffey, Kenneth W.;
Califf, Robert M.

Publication type:

Article

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial.

Published in:

European Heart Journal, 2013, v. 34, n. 23, p. 1723, doi. 10.1093/eurheartj/eht104

By:

Leonardi, Sergio;
Tricoci, Pierluigi;
White, Harvey D.;
Armstrong, Paul W.;
Huang, Zhen;
Wallentin, Lars;
Aylward, Philip E.;
Moliterno, David J.;
Van de Werf, Frans;
Chen, Edmond;
Providencia, Luis;
Nordrehaug, Jan E.;
Held, Claes;
Strony, John;
Rorick, Tyrus L.;
Harrington, Robert A.;
Mahaffey, Kenneth W.

Publication type:

Article

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Published in:

European Heart Journal, 2012, v. 33, n. 20, p. 2569

By:

Steg, Ph. Gabriel;
James, Stefan K.;
Atar, Dan;
Badano, Luigi P.;
Lundqvist, Carina Blomstrom;
Borger, Michael A.;
Di Mario, Carlo;
Dickstein, Kenneth;
Ducrocq, Gregory;
Fernandez-Aviles, Francisco;
Gershlick, Anthony H.;
Giannuzzi, Pantaleo;
Halvorsen, Sigrun;
Huber, Kurt;
Juni, Peter;
Kastrati, Adnan;
Knuuti, Juhani;
Lenzen, Mattie J.;
Mahaffey, Kenneth W.;
Valgimigli, Marco

Publication type:

Article

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.

Published in:

European Heart Journal, 2011, v. 32, n. 23, p. 2933, doi. 10.1093/eurheartj/ehr422

By:

Becker, Richard C.;
Bassand, Jean Pierre;
Budaj, Andrzej;
Wojdyla, Daniel M.;
James, Stefan K.;
Cornel, Jan H.;
French, John;
Held, Claes;
Horrow, Jay;
Husted, Steen;
Lopez-Sendon, Jose;
Lassila, Riitta;
Mahaffey, Kenneth W.;
Storey, Robert F.;
Harrington, Robert A.;
Wallentin, Lars

Publication type:

Article

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.

Published in:

European Heart Journal, 2011, v. 32, n. 19, p. 2387, doi. 10.1093/eurheartj/ehr342

By:

Fox, Keith A.A.;
Piccini, Jonathan P.;
Wojdyla, Daniel;
Becker, Richard C.;
Halperin, Jonathan L.;
Nessel, Christopher C.;
Paolini, John F.;
Hankey, Graeme J.;
Mahaffey, Kenneth W.;
Patel, Manesh R.;
Singer, Daniel E.;
Califf, Robert M.

Publication type:

Article

Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.

Published in:

European Heart Journal, 2010, v. 31, n. 8, p. 958, doi. 10.1093/eurheartj/ehp548

By:

Yan, Raymond T.;
Yan, Andrew T.;
Mahaffey, Kenneth W.;
White, Harvey D.;
Pieper, Karen;
Jie-Lena Sun;
Pepine, Carl J.;
Biasucci, Luigi M.;
Gulba, Dietrich C.;
Lopez-Sendon, Jose;
Goodman, Shaun G.

Publication type:

Article

Resolution of ST-segment depression: a new prognostic marker in ST-segment elevation myocardial infarction.

Published in:

European Heart Journal, 2010, v. 31, n. 5, p. 573

By:

Tjandrawidjaja, Michael C.;
Fu, Yuling;
Westerhout, Cynthia M.;
White, Harvey D.;
Todaro, Thomas G.;
Van de Werf, Frans;
Mahaffey, Kenneth W.;
Wagner, Galen S.;
Granger, Christopher B.;
Armstrong, Paul W.

Publication type:

Article

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Published in:

American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 12, p. 2533, doi. 10.1038/ajg.2010.445

By:

Abraham, Neena S;
Hlatky, Mark A;
Antman, Elliott M;
Bhatt, Deepak L;
Bjorkman, David J;
Clark, Craig B;
Furberg, Curt D;
Johnson, David A;
Kahi, Charles J;
Laine, Loren;
Mahaffey, Kenneth W;
Quigley, Eamonn M;
Scheiman, James;
Sperling, Laurence S;
Tomaselli, Gordon F

Publication type:

Article

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use.

Published in:

American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 11, p. 2890, doi. 10.1111/j.1572-0241.2008.02216.x

By:

Bhatt, Deepak L.;
Scheiman, James;
Abraham, Neena S.;
Antman, Elliott M.;
Chan, Francis K. L.;
Furberg, Curt D.;
Johnson, David A.;
Mahaffey, Kenneth W.;
Quigley, Eamonn M.;
Harrington, Robert A.;
Bates, Eric R.;
Bridges, Charles R.;
Eisenberg, Mark J.;
Ferrari, Victor A.;
Hlatky, Mark A.;
Kaul, Sanjay;
Lindner, Jonathan R.;
Moliterno, David J.;
Mukherjee, Debabrata;
Schofield, Richard S.

Publication type:

Article

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01619-0

By:

Tye, Sok Cin;
Jongs, Niels;
Coca, Steven G.;
Sundström, Johan;
Arnott, Clare;
Neal, Bruce;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Vart, Priya;
Heerspink, Hiddo. J. L.

Publication type:

Article

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009

By:

Rossing, Peter;
Baeres, Florian M M;
Bakris, George;
Bosch-Traberg, Heidrun;
Gislum, Mette;
Gough, Stephen C L;
Idorn, Thomas;
Lawson, Jack;
Mahaffey, Kenneth W;
Mann, Johannes F E;
Mersebach, Henriette;
Perkovic, Vlado;
Tuttle, Katherine;
Pratley, Richard

Publication type:

Article

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 7, p. 2872, doi. 10.1093/ndt/gfr777

By:

Chertow, Glenn M.;
Correa-Rotter, Ricardo;
Block, Geoffrey A.;
Drueke, Tilman B.;
Floege, Jürgen;
Goodman, William G.;
Herzog, Charles A.;
Kubo, Yumi;
London, Gerard M.;
Mahaffey, Kenneth W.;
Mix, Thomas-Christian;
Moe, Sharon M.;
Wheeler, David C.;
Parfrey, Patrick S.

Publication type:

Article

Acute Coronary Syndromes.

Published in:

Texas Heart Institute Journal, 2006, v. 33, n. 2, p. 187

By:

Mahaffey, Kenneth W.

Publication type:

Article

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.

Published in:

European Heart Journal, 2025, v. 46, n. 12, p. 1096, doi. 10.1093/eurheartj/ehae613

By:

Mahaffey, Kenneth W;
Tuttle, Katherine R;
Arici, Mustafa;
Baeres, Florian M M;
Bakris, George;
Charytan, David M;
Cherney, David Z I;
Chernin, Gil;
Correa-Rotter, Ricardo;
Gumprecht, Janusz;
Idorn, Thomas;
Pugliese, Giuseppe;
Rasmussen, Ida Kirstine Bull;
Rasmussen, Søren;
Rossing, Peter;
Sokareva, Ekaterina;
Mann, Johannes F E;
Perkovic, Vlado;
Pratley, Richard

Publication type:

Article

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.

Published in:

Diabetes Care, 2024, v. 47, n. 3, p. 501, doi. 10.2337/dc23-1450

By:

Tobe, Sheldon W.;
Mavrakanas, Thomas A.;
Bajaj, Harpreet S.;
Levin, Adeera;
Tangri, Navdeep;
Slee, April;
Neuen, Brendon L.;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Rapattoni, Wally;
Ang, Fernando G.

Publication type:

Article

Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).

Published in:

2022

By:

Ferrannini, Ele;
Baldi, Simona;
Scozzaro, Tiziana;
Tsimihodimos, Vasilis;
Tesfaye, Fisseha;
Shaw, Wayne;
Rosenthal, Norman;
Figtree, Gemma A.;
Neal, Bruce;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Hansen, Michael K.

Publication type:

journal article